# In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?

> **NCT02937155** · — · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 100 (estimated)

## Conditions studied

- HSIL, High-Grade Squamous Intraepithelial Lesions
- Adenocarcinoma in Situ
- Early Cervical Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02937155
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2021-06
- **Final completion:** 2024-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02937155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02937155, "In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02937155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*